Ahmad Golkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmad Golkar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Hedyeh Askarpour
Student Research Committee Jiroft University of Medical Sciences, Jiroft, Iran
1 shared publication- Mahdiyeh Hedayati-Moghadam
Department of Physiology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran
1 shared publication - Mahmoud Hosseini
Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication Mohammad Dalfardi
Student Research Committee Jiroft University of Medical Sciences, Jiroft, Iran
1 shared publication- Yousef Baghcheghi
Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran
1 shared publication
Latest Publications
- Open Access
- 13 January 2025
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
- Vol. 84 (4) , 371-394
Understanding the neurobiological mechanisms of LPS‑induced memory impairment
In recent years, growing evidence suggests that lipopolysaccharide (LPS), a bacterial endotoxin found in the outer membrane of gram‑negative bacteria, can influence cognitive functions, particularly memory formation and retrieval. However, the underlying mechanisms through which LPS exerts its effects on memory remain incompletely understood. This review used various electronic databases, including PubMed, Scopus, and Web of Science, to identify relevant studies published between 2000 and 2024. Articles were selected based on their focus on LPS‑induced memory impairments, including experimental models, molecular pathways, and neurochemical alterations. LPS administration has been consistently shown to disrupt memory processes in both animals and humans, although the magnitude and duration of memory impairments might vary depending on factors such as dose, timing, and context of LPS exposure. Several potential mechanisms have been proposed to explain LPS‑induced memory deficits, including neuroinflammation, alterations in synaptic plasticity, disruption of neurotransmitter systems, and dysfunction of the blood‑brain barrier. Moreover, LPS has been found to activate immune signaling pathways, such as toll‑like receptors, interleukins, and microglia, which can further contribute to cognitive impairments. Such insights may pave the way for the development of targeted therapeutic interventions aimed at ameliorating memory deficits associated with conditions involving LPS exposure, including bacterial infections, sepsis, and neuroinflammatory disorders.
- 13 January 2025
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
- Vol. 84 (4) , 371-394
Open AccessUnderstanding the neurobiological mechanisms of LPS‑induced memory impairment
In recent years, growing evidence suggests that lipopolysaccharide (LPS), a bacterial endotoxin found in the outer membrane of gram‑negative bacteria, can influence cognitive functions, particularly memory formation and retrieval. However, the underlying mechanisms through which LPS exerts its effects on memory remain incompletely understood. This review used various electronic databases, including PubMed, Scopus, and Web of Science, to identify relevant studies published between 2000 and 2024. Articles were selected based on their focus on LPS‑induced memory impairments, including experimental models, molecular pathways, and neurochemical alterations. LPS administration has been consistently shown to disrupt memory processes in both animals and humans, although the magnitude and duration of memory impairments might vary depending on factors such as dose, timing, and context of LPS exposure. Several potential mechanisms have been proposed to explain LPS‑induced memory deficits, including neuroinflammation, alterations in synaptic plasticity, disruption of neurotransmitter systems, and dysfunction of the blood‑brain barrier. Moreover, LPS has been found to activate immune signaling pathways, such as toll‑like receptors, interleukins, and microglia, which can further contribute to cognitive impairments. Such insights may pave the way for the development of targeted therapeutic interventions aimed at ameliorating memory deficits associated with conditions involving LPS exposure, including bacterial infections, sepsis, and neuroinflammatory disorders.